Report cover image

Global Quinolone Antibiotic Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 192 Pages
SKU # APRC20556883

Description

Summary

According to APO Research, the global Quinolone Antibiotic market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Quinolone Antibiotic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Quinolone Antibiotic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Quinolone Antibiotic market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Quinolone Antibiotic is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Quinolone Antibiotic market include Merck, Hebei Guangren Pharmaceutical Technology, Tianjin Glory Technology, Mercury Medicare and Healthy Life Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Quinolone Antibiotic, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Quinolone Antibiotic, also provides the sales of main regions and countries. Of the upcoming market potential for Quinolone Antibiotic, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Quinolone Antibiotic sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Quinolone Antibiotic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Quinolone Antibiotic sales, projected growth trends, production technology, application and end-user industry.

Quinolone Antibiotic Segment by Company

Merck
Hebei Guangren Pharmaceutical Technology
Tianjin Glory Technology
Mercury Medicare
Healthy Life Pharma
Quinolone Antibiotic Segment by Type

Levofloxacin
Ofloxacin
Norfloxacin
Moxifloxacin
Gatifloxacin
Ciprofloxacin
Others
Quinolone Antibiotic Segment by Application

Clinics
Hospital
Research
Others
Quinolone Antibiotic Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Quinolone Antibiotic status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Quinolone Antibiotic market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Quinolone Antibiotic significant trends, drivers, influence factors in global and regions.
6. To analyze Quinolone Antibiotic competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quinolone Antibiotic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Quinolone Antibiotic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quinolone Antibiotic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Quinolone Antibiotic market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Quinolone Antibiotic industry.
Chapter 3: Detailed analysis of Quinolone Antibiotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Quinolone Antibiotic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Quinolone Antibiotic in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

192 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Quinolone Antibiotic Sales Value (2020-2031)
1.2.2 Global Quinolone Antibiotic Sales Volume (2020-2031)
1.2.3 Global Quinolone Antibiotic Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Quinolone Antibiotic Market Dynamics
2.1 Quinolone Antibiotic Industry Trends
2.2 Quinolone Antibiotic Industry Drivers
2.3 Quinolone Antibiotic Industry Opportunities and Challenges
2.4 Quinolone Antibiotic Industry Restraints
3 Quinolone Antibiotic Market by Company
3.1 Global Quinolone Antibiotic Company Revenue Ranking in 2024
3.2 Global Quinolone Antibiotic Revenue by Company (2020-2025)
3.3 Global Quinolone Antibiotic Sales Volume by Company (2020-2025)
3.4 Global Quinolone Antibiotic Average Price by Company (2020-2025)
3.5 Global Quinolone Antibiotic Company Ranking (2023-2025)
3.6 Global Quinolone Antibiotic Company Manufacturing Base and Headquarters
3.7 Global Quinolone Antibiotic Company Product Type and Application
3.8 Global Quinolone Antibiotic Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Quinolone Antibiotic Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Quinolone Antibiotic Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Quinolone Antibiotic Market by Type
4.1 Quinolone Antibiotic Type Introduction
4.1.1 Levofloxacin
4.1.2 Ofloxacin
4.1.3 Norfloxacin
4.1.4 Moxifloxacin
4.1.5 Gatifloxacin
4.1.6 Ciprofloxacin
4.1.7 Others
4.2 Global Quinolone Antibiotic Sales Volume by Type
4.2.1 Global Quinolone Antibiotic Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Quinolone Antibiotic Sales Volume by Type (2020-2031)
4.2.3 Global Quinolone Antibiotic Sales Volume Share by Type (2020-2031)
4.3 Global Quinolone Antibiotic Sales Value by Type
4.3.1 Global Quinolone Antibiotic Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Quinolone Antibiotic Sales Value by Type (2020-2031)
4.3.3 Global Quinolone Antibiotic Sales Value Share by Type (2020-2031)
5 Quinolone Antibiotic Market by Application
5.1 Quinolone Antibiotic Application Introduction
5.1.1 Clinics
5.1.2 Hospital
5.1.3 Research
5.1.4 Others
5.2 Global Quinolone Antibiotic Sales Volume by Application
5.2.1 Global Quinolone Antibiotic Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Quinolone Antibiotic Sales Volume by Application (2020-2031)
5.2.3 Global Quinolone Antibiotic Sales Volume Share by Application (2020-2031)
5.3 Global Quinolone Antibiotic Sales Value by Application
5.3.1 Global Quinolone Antibiotic Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Quinolone Antibiotic Sales Value by Application (2020-2031)
5.3.3 Global Quinolone Antibiotic Sales Value Share by Application (2020-2031)
6 Quinolone Antibiotic Regional Sales and Value Analysis
6.1 Global Quinolone Antibiotic Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Quinolone Antibiotic Sales by Region (2020-2031)
6.2.1 Global Quinolone Antibiotic Sales by Region: 2020-2025
6.2.2 Global Quinolone Antibiotic Sales by Region (2026-2031)
6.3 Global Quinolone Antibiotic Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Quinolone Antibiotic Sales Value by Region (2020-2031)
6.4.1 Global Quinolone Antibiotic Sales Value by Region: 2020-2025
6.4.2 Global Quinolone Antibiotic Sales Value by Region (2026-2031)
6.5 Global Quinolone Antibiotic Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Quinolone Antibiotic Sales Value (2020-2031)
6.6.2 North America Quinolone Antibiotic Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Quinolone Antibiotic Sales Value (2020-2031)
6.7.2 Europe Quinolone Antibiotic Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Quinolone Antibiotic Sales Value (2020-2031)
6.8.2 Asia-Pacific Quinolone Antibiotic Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Quinolone Antibiotic Sales Value (2020-2031)
6.9.2 South America Quinolone Antibiotic Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Quinolone Antibiotic Sales Value (2020-2031)
6.10.2 Middle East & Africa Quinolone Antibiotic Sales Value Share by Country, 2024 VS 2031
7 Quinolone Antibiotic Country-level Sales and Value Analysis
7.1 Global Quinolone Antibiotic Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Quinolone Antibiotic Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Quinolone Antibiotic Sales by Country (2020-2031)
7.3.1 Global Quinolone Antibiotic Sales by Country (2020-2025)
7.3.2 Global Quinolone Antibiotic Sales by Country (2026-2031)
7.4 Global Quinolone Antibiotic Sales Value by Country (2020-2031)
7.4.1 Global Quinolone Antibiotic Sales Value by Country (2020-2025)
7.4.2 Global Quinolone Antibiotic Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.5.2 USA Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.6.2 Canada Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.8.2 Germany Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.9.2 France Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.9.3 France Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.11.2 Italy Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.12.2 Spain Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.13.2 Russia Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.16.2 China Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.16.3 China Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.17.2 Japan Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.19.2 India Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.19.3 India Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.20.2 Australia Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.24.2 Chile Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.26.2 Peru Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.28.2 Israel Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.29.2 UAE Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.31.2 Iran Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Quinolone Antibiotic Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Quinolone Antibiotic Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Quinolone Antibiotic Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck Quinolone Antibiotic Sales, Value and Gross Margin (2020-2025)
8.1.4 Merck Quinolone Antibiotic Product Portfolio
8.1.5 Merck Recent Developments
8.2 Hebei Guangren Pharmaceutical Technology
8.2.1 Hebei Guangren Pharmaceutical Technology Comapny Information
8.2.2 Hebei Guangren Pharmaceutical Technology Business Overview
8.2.3 Hebei Guangren Pharmaceutical Technology Quinolone Antibiotic Sales, Value and Gross Margin (2020-2025)
8.2.4 Hebei Guangren Pharmaceutical Technology Quinolone Antibiotic Product Portfolio
8.2.5 Hebei Guangren Pharmaceutical Technology Recent Developments
8.3 Tianjin Glory Technology
8.3.1 Tianjin Glory Technology Comapny Information
8.3.2 Tianjin Glory Technology Business Overview
8.3.3 Tianjin Glory Technology Quinolone Antibiotic Sales, Value and Gross Margin (2020-2025)
8.3.4 Tianjin Glory Technology Quinolone Antibiotic Product Portfolio
8.3.5 Tianjin Glory Technology Recent Developments
8.4 Mercury Medicare
8.4.1 Mercury Medicare Comapny Information
8.4.2 Mercury Medicare Business Overview
8.4.3 Mercury Medicare Quinolone Antibiotic Sales, Value and Gross Margin (2020-2025)
8.4.4 Mercury Medicare Quinolone Antibiotic Product Portfolio
8.4.5 Mercury Medicare Recent Developments
8.5 Healthy Life Pharma
8.5.1 Healthy Life Pharma Comapny Information
8.5.2 Healthy Life Pharma Business Overview
8.5.3 Healthy Life Pharma Quinolone Antibiotic Sales, Value and Gross Margin (2020-2025)
8.5.4 Healthy Life Pharma Quinolone Antibiotic Product Portfolio
8.5.5 Healthy Life Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Quinolone Antibiotic Value Chain Analysis
9.1.1 Quinolone Antibiotic Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Quinolone Antibiotic Sales Mode & Process
9.2 Quinolone Antibiotic Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Quinolone Antibiotic Distributors
9.2.3 Quinolone Antibiotic Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.